Tokyo Startup’s Osteoarthritis Drug Hopeful on Tap for PIb Launch by Year-End

Sansho President Toshiro Morohoshi Tokyo-based startup Sansho plans to begin a PIb trial by the end of the year for its synthesized cyclic phosphatidic acid (cPA) “2ccPA” (2-carba-cPA) for the treatment of knee osteoarthritis (OA), hoping that positive data could...read more